Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Oncogene
|
October 27, 2009
Serum protein signature may improve detection of ductal carcinoma in situ of the breast
J Solassol, P Rouanet, P J Lamy, et al.
European Journal of Pharmacology
|
July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release
C Allal, E Lazartigues, M A Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody
R Baron, E Fourcade, I Lajoie-Mazenc, et al.
Cancer Gene Therapy
|
March 15, 2008
In vivo restoration of RhoB expression leads to ovarian tumor regression
B Couderc, A Pradines, A Rafii, et al.
British Journal of Cancer
|
July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model
J-P Delord, S Quideau, P Rochaix, et al.
The Journal of Biological Chemistry
|
July 15, 2000
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription
C Allal, G Favre, B Couderc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer
Sébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Radiation Research
|
September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS
E Cohen-Jonathan, C Toulas, I Ader, et al.
British Journal of Pharmacology
|
March 28, 1998
Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor
B January, A Seibold, C Allal, et al.
British Journal of Cancer
|
January 10, 2008
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
D Balin-Gauthier, J-P Delord, M-J Pillaire, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Oncogene
|
October 27, 2009
Serum protein signature may improve detection of ductal carcinoma in situ of the breast
J Solassol, P Rouanet, P J Lamy, et al.
European Journal of Pharmacology
|
July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release
C Allal, E Lazartigues, M A Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody
R Baron, E Fourcade, I Lajoie-Mazenc, et al.
Cancer Gene Therapy
|
March 15, 2008
In vivo restoration of RhoB expression leads to ovarian tumor regression
B Couderc, A Pradines, A Rafii, et al.
British Journal of Cancer
|
July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model
J-P Delord, S Quideau, P Rochaix, et al.
The Journal of Biological Chemistry
|
July 15, 2000
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription
C Allal, G Favre, B Couderc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer
Sébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.
Radiation Research
|
September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS
E Cohen-Jonathan, C Toulas, I Ader, et al.
British Journal of Pharmacology
|
March 28, 1998
Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor
B January, A Seibold, C Allal, et al.
British Journal of Cancer
|
January 10, 2008
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
D Balin-Gauthier, J-P Delord, M-J Pillaire, et al.
Page
of 3